GE HealthCare CAO granted stock options, RSUs

GE HealthCare Technologies Inc. Chief Accounting Officer George A. Newcomb reported equity awards from the company.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. Chief Accounting Officer George A. Newcomb reported equity awards from the company. He received an employee stock option for 3,443 shares of common stock at an exercise price of $0.00 per share, and an award of 1,309 restricted stock units, each representing one share of common stock at settlement.

According to the award terms, 33% of the restricted stock units will vest on September 2, 2027, another 33% on September 2, 2028, and the remaining 34% on September 2, 2029. The stock option becomes exercisable on the same schedule: 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029. After these transactions, he directly owned 10,627 shares of common stock and had an additional 12 shares held indirectly by a family member.

Insider Trade Summary

Grant/Award: 4,752 shares

Grant/Award 3 txns

Insider Newcomb George A.

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	3,443	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	1,309	$0.00	$0.00
holding	Common Stock, par value $0.01 per share	--	--	--

Holdings After Transaction: Employee Stock Option (right to buy) — 3,443 contracts (Direct); Common Stock, par value $0.01 per share — 10,627 shares (Direct); Common Stock, par value $0.01 per share — 12 shares (Indirect, By family member)

Footnotes (3)

F1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.
F2. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.
F3. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did GEHC officer George A. Newcomb report?

George A. Newcomb reported equity awards from GE HealthCare, including 3,443 employee stock options and 1,309 restricted stock units. These awards were granted at a price of $0.00 per share as part of his compensation package and will vest over several years.

How many stock options did GEHC grant to George A. Newcomb?

GE HealthCare granted George A. Newcomb an employee stock option covering 3,443 shares of common stock at an exercise price of $0.00 per share. The option vests in three tranches, becoming exercisable between 2027 and 2029, subject to the stated vesting schedule.

What restricted stock unit award did George A. Newcomb receive from GEHC?

George A. Newcomb received 1,309 restricted stock units, each representing one share of GE HealthCare common stock at settlement. The RSUs vest 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029, if vesting conditions are satisfied.

What is the vesting schedule for George A. Newcomb’s GEHC equity awards?

Both the 1,309 restricted stock units and the 3,443 stock options vest on the same schedule: 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029. Each vesting date covers the corresponding portion of the awards.

How many GEHC shares does George A. Newcomb own after these transactions?

After the reported awards, George A. Newcomb directly owned 10,627 shares of GE HealthCare common stock. In addition, 12 shares of GE HealthCare common stock were held indirectly by a family member, as disclosed in the ownership section of the filing.

Are George A. Newcomb’s GEHC equity awards open‑market purchases or compensation grants?

The GE HealthCare transactions are compensation-related grants, not open-market purchases. They consist of a grant of 3,443 employee stock options and 1,309 restricted stock units awarded at $0.00 per share, with vesting and exercisability scheduled from 2027 through 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/04/2026 - 04:25 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Newcomb George A.

(Last)

(First)

(Middle)

500 W. MONROE STREET

(Street)

CHICAGO

60661

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	03/02/2026		A		1,309⁽¹⁾⁽²⁾	A	$0	10,627	D
Common Stock, par value $0.01 per share								12	I	By family member

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (right to buy)	$80.16	03/02/2026		A		3,443		⁽³⁾	03/02/2036	Common Stock, par value $0.01 per share	3,443	$0⁽³⁾	3,443	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

2. Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

3. Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR